For US Prescribers Only

PERSERIS logoPERSERIS logo

For US Prescribers Only

Image of a woman with curly dark hair looking away to her left.

PERSERIS® is indicated for the
treatment of schizophrenia in adults.

Needle sizes of select LAIs for schizophrenia

LAI=long-acting injectable.

Images are to scale but not actual size. Needle sizes are representations of the gauges and lengths outlined in the Prescribing Information of each product as of November 2023. Display not meant to draw comparisons of safety or efficacy.

Alt-text: Chart depicting different needle sizes for different LAIs for adult schizophrenia.

PERSERIS
(risperidone)1

Subcutaneous

Gauge: 18

Length: 5/8"

INVEGA SUSTENNA®
(paliperidone palmitate)2

Intramuscular

Gauge: 23

Length: 1"

Gauge: 22

Length: 1.5"

RISPERDAL CONSTA®
(risperidone)3

Intramuscular

Gauge: 21

Length: 1"

Gauge: 20

Length: 2"

ARISTADA®
(aripiparazole lauroxil)4

Intramuscular

Gauge: 21

Length: 1"

Gauge: 20

Length: 1.5"

Gauge: 20

Length: 2"

ARISTADA INITO®
(aripiparazole lauroxil)5

Intramuscular

Gauge: 21

Length: 1"

Gauge: 20

Length: 1.5"

Gauge: 20

Length: 2"

ABILIFY MAINTENA®
(aripiparazole)6

Intramuscular

Gauge: 23

Length: 1"

Gauge: 22

Length: 1.5"

Gauge: 21

Length: 2"

INVEGA SUSTENNA® and RISPERDAL CONSTA® are registered trademarks of Janssen Pharmaceuticals, Inc. ARISTADA® is a registered trademark of Alkermes Pharma Ireland Limited. ARISTADA INITIO® is a registered trademark of Alkermes Pharma Ireland Limited. ABILIFY MAINTENA® is a registered trademark of Otsuka Pharmaceuticals, Inc.